Seer (SEER) Amortizatization of Intangibles (2020 - 2026)
Seer (SEER) recorded quarterly Amortizatization of Intangibles of $767000.0 in Q1 2026, up 336.0% quarter-over-quarter from -$325000.0 in Q4 2025, and down 30.53% on a YoY basis from $1.1 million in Q1 2025.
Seer (SEER) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends
Seer's Amortizatization of Intangibles history runs 7 years deep, the most recent figure standing at $767000.0 for Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 30.53% year-over-year to $767000.0; the TTM figure through Mar 2026 stood at $804000.0 (down 55.48% YoY), while the FY2025 annual figure was $1.1 million, down 62.63% from the prior year.
- Amortizatization of Intangibles was $767000.0 for Q1 2026 at Seer, up from -$325000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $2.4 million in Q1 2024 to a low of -$3.2 million in Q3 2023.
- Historically, Amortizatization of Intangibles has averaged -$436470.6 across 5 years, with a median of -$132000.0 in 2022.
- The sharpest annual moves came in 2023 and 2024: Amortizatization of Intangibles sank 2510.4% in 2023, then surged 198.86% in 2024.
- A 5-year view of Amortizatization of Intangibles shows it stood at -$1.1 million in 2022, then plunged by 163.42% to -$3.0 million in 2023, then jumped by 116.45% to $494000.0 in 2024, then sank by 165.79% to -$325000.0 in 2025, then jumped by 336.0% to $767000.0 in 2026.
- The last three Amortizatization of Intangibles figures came in at $767000.0 (Q1 2026), -$325000.0 (Q4 2025), and $645000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | 13,267.00 |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Seer | 96.59 Mn | 96.59 Mn | 982,000.00 | 767,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 767,000.00 |
| Mar 31, 2026 | 767,000.00 |
| Dec 31, 2025 | -325,000.00 |
| Dec 31, 2025 | -325,000.00 |
| Sep 30, 2025 | 645,000.00 |
| Sep 30, 2025 | 645,000.00 |
| Jun 30, 2025 | -283,000.00 |
| Jun 30, 2025 | -283,000.00 |
| Mar 31, 2025 | 1.10 Mn |
| Mar 31, 2025 | 1.10 Mn |
| Dec 31, 2024 | 494,000.00 |
| Dec 31, 2024 | 494,000.00 |
| Sep 30, 2024 | 605,000.00 |
| Sep 30, 2024 | 605,000.00 |
| Jun 30, 2024 | -397,000.00 |
| Jun 30, 2024 | -397,000.00 |
| Mar 31, 2024 | 2.35 Mn |
| Mar 31, 2024 | 2.35 Mn |
| Dec 31, 2023 | -3.00 Mn |
| Dec 31, 2023 | -3.00 Mn |